Capricor Therapeutics
CAPR
#6423
Rank
โ‚ฌ0.52 B
Marketcap
11,23ย โ‚ฌ
Share price
-1.53%
Change (1 day)
125.47%
Change (1 year)

Revenue for Capricor Therapeutics (CAPR)

Revenue in 2024 (TTM): โ‚ฌ20.96 Million

According to Capricor Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ19.49 Million. a decrease over the revenue in the year 2023 that were of โ‚ฌ22.77 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Capricor Therapeutics from 2009 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ21.4 M-6.04%
2023 โ‚ฌ22.77 M857.54%
2022 โ‚ฌ2.37 M999.96%
2021 โ‚ฌ0.21 M-14.27%
2020 โ‚ฌ0.25 M-71.88%
2019 โ‚ฌ0.89 M-38.59%
2018 โ‚ฌ1.46 M-19.98%
2017 โ‚ฌ1.82 M-39.8%
2016 โ‚ฌ3.03 M-12.18%
2015 โ‚ฌ3.45 M0.8%
2014 โ‚ฌ3.42 M
2013 N/A-100%
2012 โ‚ฌ0.14 M-85.83%
2011 โ‚ฌ1.04 M
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ16.16 M-17.05%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.3 M-98.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ78.18 B 401,018.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.06 B 10,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.14 M-68.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.5 M-97.39%๐Ÿ‡บ๐Ÿ‡ธ USA